Ferring Wins Lysteda Patent Trial Against Watson, Apotex

Law360, Los Angeles (February 3, 2014, 10:06 PM EST) -- Ferring Pharmaceuticals Inc. announced Monday that it had won a patent infringement trial against Watson Pharmaceuticals Inc. and Apotex Inc., with a Nevada federal court finding that the defendants infringed Ferring's patents for the heavy menstrual bleeding medication Lysteda.

Following a bench trial, the court found that Ferring's patents were valid and infringed by both Watson and Apotex, according to Ferring. Additional details of the court's ruling were not immediately available Monday.

The verdicts in Ferring's favor resolve a consolidated lawsuit that dates back nearly three...
To view the full article, register now.